LoginSignup
MED

Medifast

Stock
Stock
ISIN: US58470H1014
Ticker: MED
US58470H1014
MED

Price

Price

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 07.02.2025

$2.129

CHART BY

Frequently asked questions

What is Medifast's market capitalization?

The market capitalization of Medifast is $200.16M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Medifast's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Medifast is 27.33. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Medifast?

Medifast's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.669. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Medifast's stock?

Currently, 2 analysts cover Medifast's stock, with a consensus target price of $21.25. Analyst ratings provide insights into the stock's expected performance.

What is Medifast's revenue over the trailing twelve months?

Over the trailing twelve months, Medifast reported a revenue of $674.48M.

What is the EBITDA for Medifast?

Medifast's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $23.72M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Medifast?

Medifast has a free cash flow of $15.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Medifast's stock?

The 5-year beta for Medifast is 1.18. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Medifast have, and what sector and industry does it belong to?

Medifast employs approximately 634 people. It operates in the Consumer Staples sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Medifast's shares?

The free float of Medifast is 10.66M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $200.16M

5Y beta

 1.18

EPS (TTM)

 $0.669

Free Float

 10.66M

P/E ratio (TTM)

 27.33

Revenue (TTM)

 $674.48M

EBITDA (TTM)

 $23.72M

Free Cashflow (TTM)

 $15.14M

Pricing

1D span
$18.28$18.32
52W span
$17.07$76.42

Analyst Ratings

The price target is $21.25 and the stock is covered by 2 analysts.

Buy

0

Hold

1

Sell

1

Information

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.

634

Biotechnology & Drugs

Consumer Staples

Identifier

ISIN

US58470H1014

Primary Ticker

MED

Knockouts

Join the conversation
Sign upLogin